The Net Margin of Shanghai Henlius Biotech Inc (2696.HK) is 14.33%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date | Value |
|---|---|
| 2024-12-31 | 14.33% |
| 2023-12-31 | 10.12% |
| 2022-12-31 | -21.63% |
| 2021-12-31 | -58.49% |
| 2020-12-31 | -169.09% |
| 2019-12-31 | -962.80% |
| 2018-12-31 | -6652.55% |
| 2017-12-31 | -797.88% |